Karyopharm Therapeutics

-$0.31 (-3.53%) As of 6:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).

CEO

Richard A. Paulson

Employees

432

Headquarters

Newton, Massachusetts

Founded

2008

KPTI Key Statistics

Market Cap

708.12M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.05M

High Today

$8.91

Low Today

$8.38

Open Price

$8.77

Volume

566.56K

52 Week High

$18.00

52 Week Low

$7.78

Analyst Ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

KPTI Earnings

-$0.78

-$0.52

-$0.26

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 10, Pre-Market